quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:15:00·8d
PRRelease
Illumina Inc. logo

DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows

ILMN· Illumina Inc.
Health Care
Original source

Companies

  • ILMN
    Illumina Inc.
    Health Care

Recent analyst ratings

  • Aug 12UpdateDaiwa Securities$94.00
  • Jul 11UpdateScotiabank$125.00
  • Mar 4UpdateCitigroup$90.00
  • Feb 28UpdateHSBC Securities$100.00
  • Feb 10UpdateBarclays$100.00
  • Feb 7UpdateTD Cowen$140.00

Related

  • PR10d
    Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease
  • PR14d
    Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026
  • SEC14d
    SEC Form DEFA14A filed by Illumina Inc.
  • SEC14d
    SEC Form DEF 14A filed by Illumina Inc.
  • INSIDER21d
    SEC Form 4 filed by Ullem Scott B.
  • INSIDER21d
    SEC Form 4 filed by Meister Keith A.
  • SEC22d
    Illumina Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR22d
    Illumina Announces Changes to Board of Directors
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022